Practice
Open Access

Remdesivir for patients with COVID-19

Peter E. Wu and Andrew M. Morris
CMAJ January 25, 2021 193 (4) E125; DOI: https://doi.org/10.1503/cmaj.202505
Submit a Response to This Article
Compose Response

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
References
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Minimum 7 characters.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'. Minimum 12 characters.
Your organization, institution's or residential address.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No Responses have been published for this article.
Back to top

In this issue

Canadian Medical Association Journal: 193 (4)
CMAJ
Vol. 193, Issue 4
25 Jan 2021

Article tools

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Remdesivir for patients with COVID-19
Peter E. Wu, Andrew M. Morris
CMAJ Jan 2021, 193 (4) E125; DOI: 10.1503/cmaj.202505
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo

Jump to section

Related Articles

  • No related articles found.

Cited By...

  • No citing articles found.

More in this TOC Section

Similar Articles

Collections